Novo Nordisk A/S
Send to a friendPrint

Acquired Haemophilia


Acquired haemophilia is a spontaneous development of inhibitors to one’s own FVIII.  Acquired haemophilia occurs in about one person per million. The underlying cause of inhibitor development is usually idiopathic (unknown) but may occur in relation to pregnancy, autoimmune disease, the use of certain medications or cancer. Patients with acquired haemophilia may present to the hospital as a result of a severe spontaneous bleeding episode. These bleeding episodes are very difficult to control, and will not typically respond to treatment with FVIII.

 


 

For information on Haemophilia, please refer to following links:

For general information on Bleeding Disorders: www.wfh.org
Home > About Bleeding Disorders

Specialist information:
www.haemostasis-forum.org

NNHF is not responsible for the content of any external websites. The featuring of a site on this page is not an endorsement by NNHF of the information or views expressed therein.